Khaled Musallam: Earlier Recognition, Better Outcomes in NTDT
Khaled Musallam, Group Chief Research Officer at Burjeel Holdings, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Blood Advances, adding:
”Pleased to share another new Editorial out today in Blood Advances, a journal of the American Society of Hematology: ‘Too little, too late? The burden of delayed care in NTDT.’
A challenge that remains very real in non-transfusion-dependent thalassemia (NTDT) is delayed recognition, diagnosis, and referral to specialist care, with many patients reaching adulthood having already developed serious morbidities.
A reminder that NTDT is not a mild disease and that earlier recognition, specialist referral, and timely intervention can change its trajectory.”
Title: Too little, too late? The burden of delayed care in NTDT
Authors: Khaled M. Musallam, Thomas D. Coates, Ali T. Taher
Find more posts featuring Khaled Musallam on Hemostasis Today.
-
Oct 27, 2026, 16:28Rose Agor: Celebrating Two New Publications in Haematology Research
-
Oct 27, 2026, 16:21Pregnancy and Thrombosis-What Clinicians Need to Know – World Thrombosis Day
-
Oct 27, 2026, 16:13Lesley Van Wyk: DIC vs TTP vs HUS – The Key Diagnostic Clues
-
Oct 27, 2026, 16:02Ahmad G. Alzahrani: AF and Vascular Risk Factors – Should We Add Antiplatelet Therapy?
-
Oct 27, 2026, 16:02Iron Deficiency and Thrombocytosis: How Iron Availability Shapes Hematopoietic Lineage Decisions
-
Oct 27, 2026, 15:46Christiane Berger-Schaffitzel: New PhD Project Explores Snake Venom and Haemostasis
-
Oct 27, 2026, 13:51Muhammed Hajmusa: ESMO 2026 Highlights the Challenge of Anticoagulation in ROS1-Positive Lung Cancer
-
Oct 27, 2026, 13:39Luca Galassi: Retrieved Venous Thrombi as a Tool for Predicting Post-Thrombotic Syndrome
-
Oct 27, 2026, 11:43Tareq Abadl: Hidden Interferences Behind Unexpected Laboratory Results